Literature DB >> 12016123

IL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cells.

Philippe Mathurin1, Shigang Xiong, Kusum K Kharbanda, Nary Veal, Takeo Miyahara, Kenta Motomura, Richard A Rippe, Max G Bachem, Hidekazu Tsukamoto.   

Abstract

Interleukin (IL)-10 expression is induced in activated hepatic stellate cells (HSC) in vitro and in vivo. We analyzed expression of IL-10 receptor (IL-10R) and coreceptor cytokine receptor family (CRF2-4) in HSC. We aimed to clone and sequence partial cDNA for rat IL-10R and CRF2-4, determine their expression in activated rat HSC in vivo and in vitro, and examine the biological responsiveness of HSC to exogenous IL-10. PCR cloning and sequencing of partial rat IL-10R and CRF2-4 cDNAs revealed 86% homology with corresponding mouse sequences. In hepatic macrophages, Northern blot with cloned IL-10R cDNA detected an expected 3.5-kb transcript, and IL-10R and CRF2-4 mRNAs showed steady constitutive expression after in vitro lipopolysaccharide treatment or cholestatic liver injury. IL-10R mRNA expression, as confirmed by immunohistochemistry, was induced 20.1- and 8.6-fold in HSC from cholestatic livers and 7-day culture-activated HSC, respectively but CRF2-4 mRNA levels were unchanged. Under serum-free conditions, IL-10 had minimal effects on collagen production but reduced DNA synthesis, matrix metalloprotease-2 mRNA levels, and activity in HSC. With serum, IL-10 inhibited both collagen production and DNA synthesis but had no effect on procollagen-alpha(1)(I) mRNA levels. This shows concomitant induction of IL-10R but not CRF2-4 to that of IL-10 by activated HSC in vitro and in vivo and associated acquisition of the responsiveness to IL-10, entailing complex effects on HSC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016123     DOI: 10.1152/ajpgi.00293.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  11 in total

1.  Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells.

Authors:  Cleverson Moraes de Oliveira; Leo Anderson Meira Martins; Arieli Cruz de Sousa; Ketlen da Silveira Moraes; Bruna Pasqualotto Costa; Moema Queiroz Vieira; Bárbara Paranhos Coelho; Radovan Borojevic; Jarbas Rodrigues de Oliveira; Fátima Costa Rodrigues Guma
Journal:  Mol Cell Biochem       Date:  2020-10-19       Impact factor: 3.396

2.  Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis.

Authors:  Heni Rachmawati; Leonie Beljaars; Catharina Reker-Smit; Anne-miek M Van Loenen-Weemaes; Werner I Hagens; Dirk K F Meijer; Klaas Poelstra
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

3.  Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis.

Authors:  Jie Luo; Yuejin Liang; Fanping Kong; Jingfan Qiu; Xinjian Liu; Ailing Chen; Bruce A Luxon; Hannah W Wu; Yong Wang
Journal:  Immunol Cell Biol       Date:  2016-11-03       Impact factor: 5.126

Review 4.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

5.  Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.

Authors:  Violaine Arnaud; Jun Li; Yuanyuan Wang; Xiao Fu; Shi Mengzhi; Xinsong Luo; Xunya Hou; Helia Dessein; Zhou Jie; Yu Xin-Ling; Hongbin He; Donald P McManus; Yuesheng Li; Alain Dessein
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

Review 6.  Interferon-beta responders and non-responders. A biological approach.

Authors:  Antonio Bertolotto; Francesca Gilli
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

7.  Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.

Authors:  A A Higazi; M El-Haj; A Melhem; A Horani; O Pappo; C E Alvarez; N Muhanna; S L Friedman; R Safadi
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

Review 8.  Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches.

Authors:  Areeba Ahmad; Riaz Ahmad
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

Review 9.  Interleukins in chronic liver disease: lessons learned from experimental mouse models.

Authors:  Linda Hammerich; Frank Tacke
Journal:  Clin Exp Gastroenterol       Date:  2014-09-01

10.  HGF and IL-10 expressing ALB::GFP reporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model.

Authors:  Ja Sung Choi; In Sil Jeong; Young-Jin Park; Sung-Whan Kim
Journal:  Stem Cell Res Ther       Date:  2020-08-03       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.